The FDA flagged potential safety signals for colitis with Ibrance, Kisqali and Verzenio, and heart inflammation with melanoma drugs. No causal link is confirmed.
|Articles|July 10, 2015
Kara Maxwell Provides Advice for a Patient With Early Stage Breast Cancer
Author(s)Kara Maxwell
Kara Maxwell, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, provides advice for a patient with early stage breast cancer.
Advertisement
Kara Maxwell, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, provides advice for a patient with early stage breast cancer.
Advertisement
Related to this article
Three doctors dismissed Christine Kushner’s breast changes at 37. Trusting her gut and pushing for a mammogram helped save her life.
Five CURE bloggers living with breast cancer share what Breast Cancer Awareness Month can miss, from metastatic disease to men and mammogram limits.
A study of 39,184 people with solid tumors, published Oct. 8, 2026, found that about 1 in 6 had an inherited genetic change that increased their cancer risk. Testing only people under 50 would have missed 72% of those with these changes.
In a video interview with CURE, Dr. Elizabeth K. Lee explained that how a treatment affects daily life matters as much as how well it works.
Dr. Neel Chudgar of Montefiore Einstein answers the most searched questions about lung cancer surgery, including risks, recovery and recurrence.
Rinatabart sesutecan shrank tumors in 45.9% of patients with platinum-resistant ovarian cancer in a phase 2 study, with responses lasting a median of 12.1 months.
In a trial of 2,175 people with early HER2-positive breast cancer, 43.8% had no invasive cancer left after 12 weeks of a lighter regimen, and certain tumor features predicted who was most likely to respond.
Advertisement
Advertisement
Trending on CURE
1
Why Biomarker Testing Can Change a Brain Tumor Diagnosis
2
FDA Flags Possible Colitis Risk With CDK4/6 Breast Cancer Drugs
3
Radioligand Plus Radiation Delays Prostate Cancer Progression to 17.6 Months
4
What Is a Personalized Cancer Vaccine? What Patients Should Know
5